FDG-PET/CT in infections: The imaging method of choice?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 10, 2010, Pages 1986-1991

  Glaudemans, Andor W J M ^a   Signore, Alberto ^a,b,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIABETIC FOOT; DISKITIS; ECHINOCOCCOSIS; ENTERITIS; GRAFT INFECTION; INFECTION; NEUROPATHIC JOINT DISEASE; OSTEOMYELITIS; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PROSTHESIS INFECTION; PYREXIA IDIOPATHICA; RISK BENEFIT ANALYSIS; SOFT TISSUE INFECTION; SPONDYLITIS; TREATMENT RESPONSE; TUBERCULOSIS; VASCULITIS; HUMAN; LETTER; METHODOLOGY; RADIOGRAPHY; SCINTISCANNING;

FLUORODEOXYGLUCOSE F18; HUMANS; INFECTION; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79952112119     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-010-1587-x     Document Type: Article

References (26)

1. Signore A, Soroa VA, De Vries EF. Radiobelled white blood cells or FDG for imaging on inflammation and infection? Q J Nucl Med Mol Imaging. 2009;53(1):23-5.
2. Balink H, Collins J, Bruyn G, Gemmel F. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med. 2009;34 (12):862-8.
3. Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2009;39(1):36-51.
4. Jasper N, Däbritz J, Frosch M, Loeffler M, Weckesser M, Foell D. Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation. Eur J Nucl Med Mol Imaging. 2010;37(1):136-45.
5. Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med. 2010;36(3):504-11.
6. Castaigne C, Tondeur M, de Wit S, Hildebrand M, Clumeck N, Dusart M. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Commun. 2009;30 (1):41-7.
7. Palestro CJ, Love C, Bhargava KK. Labeled leukocyte imaging: current status and future directions. Q J Nucl Med Mol Imaging. 2009;53(1):105-23.
8. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med. 2010;40 (1):3-15.
9. Ito K, Kubota K, Morooka M, Hasuo K, Kuroki H, Mimori A. Clinical impact of 18F-FDG PET/CT on the management and diagnosis of infectious spondylitis. Nucl Med Commun. 2010;31 (8):691-8.
10. Gemmel F, Rijk PC, Collins JM, Parlevliet T, Stumpe KD, Palestro CJ. Expanding role of 18F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections. Eur Spine J. 2010;19 (4):540-51.
11. Nawaz A, Torigian DA, Siegelman ES, Basu S, Chryssikos T, Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol. 2010;12(3):335-42.
12. Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin Nucl Med. 2009;39(1):66-78.
13. Keidar Z, Nitecki S. FDG-PET for the detection of infected vascular grafts. Q J Nucl Med Mol Imaging. 2009;53(1):35-40.
14. Spacek M, Belohlavek O, Votrubova J, Sebesta P, Stadler P. Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging. 2009;36(5):850-8.
15. Menezes LJ, Kotze CW, Hutton BF, Endozo R, Dickson JC, Cullum I, et al. Vascular inflammation imaging with 18F-FDG PET/CT: when to image? J Nucl Med. 2009;50(6):854-7.
16. Zerizer I, Tan K, Khan S, Barwick T, Marzola MC, Rubello D, et al. Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol. 2010;73(3):504-9.
17. Imperiale A, Federici L, Lefebvre N, Braun JJ, Pfumio F, Kessler R, et al. F-18 FDG PET/CT as a valuable imaging tool for assessing treatment efficacy in inflammatory and infectious diseases. Clin Nucl Med. 2010;35:86-90.
18. Glaudemans AW, Maccioni F, Mansi L, Dierckx RA, Signore A. Imaging of cell trafficking in Crohn's disease. J Cell Physiol. 2010;223(3):562-71.
19. Sathekge M, Goethals I, Maes A, Van de Wiele C. Positron emission tomography in patients suffering from HIV-1 infection. Eur J Nucl Med Mol Imaging. 2009;36(7):1176-84.
20. Sathekge M, Maes A, Kgomo M, Van de Wiele C. Fluorodeox-yglucose uptake by lymph nodes of HIV patients is inversely related to CD4 cell count. Nucl Med Commun. 2010;31(2):137-40.
21. Sathekge M, Goethals I, Maes A, Van de Wiele C. Positron emission tomography in patients suffering from HIV-1 infection. Eur J Nucl Med Mol Imaging. 2009;36(7):1176-84.
22. Lucignani G, Orunesu E, Cesari M, Marzo K, Pacei M, Bechi G, et al. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imaging. 2009;36(4):640-7.
23. Sathekge M, Maes A, Kgomo M, Stoltz A, Pottel H, Van de Wiele C. Impact of FDG PET on the management of TBC treatment. A pilot study. Nuklearmedizin. 2010;49(1):35-40.
24. Hadley GP, Naude F. Malignant solid tumour, HIV infection and tuberculosis in children: an unholy triad. Pediatr Surg Int. 2009;25 (8):697-701.
25. Sathekge M, Maes A, Al Nahhas A, Rubello D, Chiti A. What impact can fluorine-18 fluorodeoxyglucose PET/computed tomography have on HIV/AIDS and tuberculosis pandemic? Nucl Med Commun. 2009;30(4):255-7.
26. Dumarey N. Imaging with FDG labeled leukocytes: is it clinically useful? Q J Nucl Med Mol Imaging. 2009;53(1):89-94.